Published in Cold Spring Harb Perspect Med on July 01, 2012
Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90
Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A (2013) 1.10
Cell therapy for type 1 diabetes. QJM (2014) 0.99
Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis. Development (2015) 0.97
Animal models of diabetes mellitus for islet transplantation. Exp Diabetes Res (2012) 0.96
Inflammatory response in islet transplantation. Int J Endocrinol (2014) 0.91
Ectopic transplantation sites for cell-based therapy. Curr Opin Organ Transplant (2014) 0.90
The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One (2013) 0.87
Theranostic magnetic resonance imaging of type 1 diabetes and pancreatic islet transplantation. Quant Imaging Med Surg (2012) 0.85
Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo. Stem Cells Transl Med (2015) 0.84
Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways. PLoS One (2014) 0.84
Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3. Rev Diabet Stud (2014) 0.80
Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors. Transplantation (2014) 0.79
Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel. Biomaterials (2013) 0.79
Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells. Stem Cells Transl Med (2014) 0.79
No evidence of viral transmission following long-term implantation of agarose encapsulated porcine islets in diabetic dogs. J Diabetes Res (2014) 0.78
Size effect of engineered islets prepared using microfabricated wells on islet cell function and arrangement. Heliyon (2016) 0.77
Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis. PLoS One (2016) 0.77
Targeted immune interventions for type 1 diabetes: not as easy as it looks! Curr Opin Endocrinol Diabetes Obes (2014) 0.77
Tissue engineering approaches to cell-based type 1 diabetes therapy. Tissue Eng Part B Rev (2014) 0.77
Different digestion enzymes used for human pancreatic islet isolation: a mixed treatment comparison (MTC) meta-analysis. Islets (2014) 0.76
Human islet mass, morphology, and survival after cryopreservation using the Edmonton protocol. Islets (2014) 0.76
The cell cycle as a brake for β-cell regeneration from embryonic stem cells. Stem Cell Res Ther (2016) 0.75
Parathyroid Hormone-Related Peptide (1-36) Enhances Beta Cell Regeneration and Increases Beta Cell Mass in a Mouse Model of Partial Pancreatectomy. PLoS One (2016) 0.75
Monitoring of Allogeneic Islet Grafts in Nonhuman Primates Using MRI. Transplantation (2015) 0.75
Nonhuman primate models of type 1 diabetes mellitus for islet transplantation. J Diabetes Res (2014) 0.75
Imaging of Hydrogel Microsphere Structure and Foreign Body Response Based on Endogenous X-Ray Phase Contrast. Tissue Eng Part C Methods (2016) 0.75
Cell Therapy in Myology: Dynamics of Muscle Precursor Cell Death after Intramuscular Administration in Non-human Primates. Mol Ther Methods Clin Dev (2017) 0.75
Economic 3D-printing approach for transplantation of human stem cell-derived β-like cells. Biofabrication (2016) 0.75
Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient mice. World J Diabetes (2016) 0.75
Bioengineered stem cells as an alternative for islet cell transplantation. World J Transplant (2015) 0.75
Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats. J Diabetes Investig (2016) 0.75
Gene therapy for type 1 diabetes moves a step closer to reality. Diabetes (2013) 0.75
Optimizing Porcine Islet Isolation to Markedly Reduce Enzyme Consumption Without Sacrificing Islet Yield or Function. Transplant Direct (2016) 0.75
Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. Proc Natl Acad Sci U S A (2017) 0.75
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA (2005) 4.48
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant (2005) 3.07
Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57
Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant (2004) 2.55
Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet (2005) 2.39
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36
Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes (2002) 2.28
Automated islet isolation from human pancreas. Diabetes (1989) 2.13
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant (2010) 2.06
Transplantation of intact pancreatic islets in rats. Surgery (1972) 2.05
Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant (2008) 2.03
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes (2005) 1.96
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84
Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes (1989) 1.81
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care (2006) 1.80
Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation (2007) 1.78
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev (2004) 1.73
Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67
Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation (2008) 1.66
Optimal implantation site for pancreatic islet transplantation. Br J Surg (2008) 1.65
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia (2005) 1.62
Bone marrow as an alternative site for islet transplantation. Blood (2009) 1.61
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int (2009) 1.58
Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation (2011) 1.46
Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45
Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev (2009) 1.41
Positron emission tomography in clinical islet transplantation. Am J Transplant (2009) 1.37
Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes (2001) 1.33
Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med (2007) 1.29
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant (2009) 1.27
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation (2007) 1.23
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation (2010) 1.23
Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23
Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes (2010) 1.20
Improvement in islet yield from obese donors for human islet transplants. Transplantation (2004) 1.19
Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant (2011) 1.18
A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation (2008) 1.18
Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes (2004) 1.13
Histologic graft assessment after clinical islet transplantation. Transplantation (2009) 1.12
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12
Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant (2008) 1.11
Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant (2007) 1.11
Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation (2009) 1.11
Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant (2011) 1.10
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation (2010) 1.10
Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes (2003) 1.10
The standardization of pancreatic donors for islet isolations. Transplantation (2005) 1.07
MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol (2009) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation (2010) 1.06
Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation (2007) 1.05
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03
Autoimmune diabetes and the circle of tolerance. Diabetes (2004) 1.03
Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant (2006) 1.01
Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark. Am J Transplant (2008) 0.99
Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes (1994) 0.99
Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud (2011) 0.98
Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant (2011) 0.98
Acute portal hypertension and disseminated intravascular coagulation following pancreatic islet autotransplantation after subtotal pancreatectomy. Transplantation (1981) 0.96
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology (2008) 0.94
Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation. Cell Transplant (2009) 0.93
Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation (1998) 0.93
Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant (2004) 0.92
Tetramer analysis of human autoreactive CD4-positive T cells. Adv Immunol (2005) 0.90
Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant Proc (1993) 0.88
Recurrence of autoimmunity following pancreas transplantation. Curr Diab Rep (2011) 0.88
Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant (2006) 0.88
Detrimental effect of excessive collagenase class II on human islet isolation outcome. Transpl Int (2008) 0.87
Validation of the scoring system for standardization of the pancreatic donor for islet isolation as used in a new islet isolation center. Transplant Proc (2006) 0.86
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice. Surgery (2011) 0.86
Chemical immunosuppression in islet transplantation--friend or foe? N Engl J Med (2008) 0.86
The correlation between donor characteristics and the success of human islet isolation. Transplantation (1994) 0.83
Survival of pancreatic islet xenografts in NOD mice with the theracyte device. Transplant Proc (2002) 0.83
Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes (2002) 0.82
Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations. Cell Transplant (2010) 0.82
TransEndoscopic Gastric SubMucosa Islet Transplantation (eGSM-ITx) in pigs with streptozotocine induced diabetes - technical aspects of the procedure - preliminary report. Ann Transplant (2009) 0.81
Artificial pancreas using living beta cells:. effects on glucose homeostasis in diabetic rats. Science (1977) 0.81
Detrimental effect of prednisone on canine islet autograft function. Transplant Proc (1992) 0.81
Recurrence of autoimmunity in pancreas transplant patients: research update. Diabetes Manag (Lond) (2011) 0.81
CTLA-4Ig is finally making it: a personal perspective. Am J Transplant (2005) 0.80
Imaging the islet graft by positron emission tomography. Eur J Nucl Med Mol Imaging (2011) 0.79
Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination. Transplant Proc (1998) 0.78
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology (2010) 3.54
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology (2009) 2.51
Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36
Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes (2009) 2.31
Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes (2004) 2.22
Cell encapsulation: promise and progress. Nat Med (2003) 2.18
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04
Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl (2004) 1.80
Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant (2007) 1.78
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76
Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes (2002) 1.61
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int (2009) 1.58
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol (2009) 1.53
Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes (2004) 1.46
Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation (2015) 1.44
Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care (2005) 1.35
Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34
Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes (2002) 1.32
Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant (2007) 1.27
Current status of clinical islet cell transplantation. Methods Mol Biol (2006) 1.25
Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23
Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes (2006) 1.21
Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation (2004) 1.17
Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant (2007) 1.14
Estimation of pancreas weight from donor variables. Cell Transplant (2006) 1.13
Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation (2006) 1.12
Histologic graft assessment after clinical islet transplantation. Transplantation (2009) 1.12
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11
Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic β-cells through glycolysis and calcium channels. Endocrinology (2011) 1.11
Current status of pancreatic islet transplantation. Clin Sci (Lond) (2006) 1.11
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation (2010) 1.10
Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab (2006) 1.08
Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther (2006) 1.08
Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation (2010) 1.06
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes (2006) 1.05
Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol (2013) 1.04
Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03
Surgical aspects of human islet isolation. Islets (2010) 1.03
Circumportal pancreas and islet isolation. Surgery (2008) 1.03
Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs (2004) 1.01
Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int (2008) 1.00
Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant (2004) 1.00
Risks and side effects of islet transplantation. Curr Diab Rep (2004) 1.00
Beta-cell transplantation for diabetes therapy. Lancet (2008) 0.99
Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation (2007) 0.98
Current indications for pancreas or islet transplant. Diabetes Obes Metab (2006) 0.98
Technical aspects of islet preparation and transplantation. Transpl Int (2003) 0.98
Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes (2007) 0.97
Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras. J Immunol (2008) 0.95
Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl (2010) 0.95
Role of imaging in clinical islet transplantation. Radiographics (2010) 0.95
Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. Endocrinology (2009) 0.95
The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes (2008) 0.95
Unraveling the secrets of single donor success in islet transplantation. Am J Transplant (2004) 0.94
Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. Transplantation (2010) 0.94
Pancreas divisum: a study of the cadaveric donor pancreas for islet isolation. Pancreas (2005) 0.94
High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation. Transpl Int (2009) 0.93
A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation. J Hepatobiliary Pancreat Sci (2012) 0.93
Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation (2006) 0.93
Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation (2002) 0.93
Histopaque provides optimal mouse islet purification kinetics: comparison study with Ficoll, iodixanol and dextran. Islets (2011) 0.92
Changes in liver enzymes after clinical islet transplantation. Transplantation (2003) 0.92
Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant (2006) 0.92
Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can (2005) 0.91
Islet transplantation: progress and challenge. Arch Med Res (2005) 0.91
Detection of microbial contamination during human islet isolation. Cell Transplant (2007) 0.90
Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation (2004) 0.90
Islet transplants and impact on secondary diabetic complications: does C-Peptide protect the kidney? J Am Soc Nephrol (2003) 0.90
Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation (2004) 0.90
Experience of islet isolation without neutral protease supplementation. Islets (2010) 0.90
Enriched human pancreatic ductal cultures obtained from selective death of acinar cells express pancreatic and duodenal homeobox gene-1 age-dependently. Rev Diabet Stud (2004) 0.90
Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy. Can J Surg (2011) 0.90
Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur J Immunol (2007) 0.88
Pancreatic islet autotransplantation with completion pancreatectomy in the management of uncontrolled pancreatic fistula after whipple resection for ampullary adenocarcinoma. Pancreas (2006) 0.87
Are stem cells a cure for diabetes? Clin Sci (Lond) (2009) 0.87
Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation. Transplantation (2009) 0.87
Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus. Transplantation (2014) 0.87
Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation (2002) 0.87
Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation (2005) 0.86
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice. Surgery (2011) 0.86
Clinical islet transplantation at the University of Alberta--the Edmonton experience. Clin Transpl (2005) 0.86
Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model. Surgery (2011) 0.86
Quantitative assessment of collagenase blends for human islet isolation. Transplantation (2005) 0.86
Follow-up study of the first successful living donor islet transplantation. Transplantation (2006) 0.85
Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation (2002) 0.85
Further evidence for amyloid deposition in clinical pancreatic islet grafts. Transplantation (2012) 0.85
Reduced fear of hypoglycemia in successful islet transplantation. Diabetes Care (2004) 0.84
Functional plasticity of the human infant β-cell exocytotic phenotype. Endocrinology (2013) 0.84
An isolated venous sac as a novel site for cell therapy in diabetes mellitus. Transplantation (2012) 0.84
The role of macrophage migration inhibitory factor in mouse islet transplantation. Transplantation (2008) 0.82
The use of an approved biodegradable polymer scaffold as a solid support system for improvement of islet engraftment. Artif Organs (2008) 0.82
Cross-sectional and prospective association between proinsulin secretion and graft function after clinical islet transplantation. Transplantation (2004) 0.82
Hepatic artery-portal venous fistula after percutaneous intraportal islet cell transplant. Transplantation (2007) 0.81
Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation (2007) 0.81
Endogenous pancreatic enzyme activity levels show no significant effect on human islet isolation yield. Cell Transplant (2004) 0.81